CI
NTR icon

Clal Insurance’s Nutrien NTR Stock Holding History

Clal Insurance’s Portfolio NTR Stock Details NTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$165M Sell
2,175,282
-210,000
-9% -$15M 0.99% 23
2025
Q4 		$148M Sell
2,385,282
-600,000
-20% -$35.3M 0.96% 25
2025
Q3 		$177M Sell
2,985,282
-100,000
-3% -$5.83M 1.35% 19
2025
Q2 		$181M Buy
3,085,282
+400,000
+15% +$22.6M 1.78% 16
2025
Q1 		$135M Buy
2,685,282
+190,000
+8% +$9.72M 1.39% 17
2024
Q4 		$113M Hold
2,495,282
– – 1.01% 27
2024
Q3 		$121M Buy
2,495,282
+1,100,000
+79% +$53M 1.07% 27
2024
Q2 		$71.8M Buy
1,395,282
+510,000
+58% +$27.9M 0.75% 31
2024
Q1 		$48.6M Buy
885,282
+534,000
+152% +$27.8M 0.55% 47
2023
Q4 		$20M Sell
351,282
-1,010,000
-74% -$57.1M 0.26% 65
2023
Q3 		$84.8M Buy
1,361,282
+1,150,000
+544% +$72.8M 1.18% 19
2023
Q2 		$12.6M Sell
211,282
-2,311,871
-92% -$147M 0.15% 79
2023
Q1 		$188M Sell
2,523,153
-1,070,000
-30% -$82.6M 2.81% 10
2022
Q4 		$264M Sell
3,593,153
-361,039
-9% -$28.5M 3.96% 3
2022
Q3 		$332M Sell
3,954,192
-74,646
-2% -$6.42M 4.55% 3
2022
Q2 		$323M Sell
4,028,838
-1,990,317
-33% -$193M 4.3% 3
2022
Q1 		$629M Buy
6,019,155
+1,456,027
+32% +$121M 6.63% 2
2021
Q4 		$343M Buy
4,563,128
+1,741,558
+62% +$122M 3.71% 3
2021
Q3 		$183M Buy
2,821,570
+45,500
+2% +$2.78M 2.09% 12
2021
Q2 		$168M Buy
2,776,070
+272,567
+11% +$16.1M 1.92% 11
2021
Q1 		$135M Buy
2,503,503
+940,000
+60% +$51.1M 1.56% 18
2020
Q4 		$70.4M Buy
1,563,503
+600,000
+62% +$26.5M 0.96% 38
2020
Q3 		$37.8M Buy
963,503
+659,826
+217% +$24M 0.64% 53
2020
Q2 		$9.75M Buy
303,677
+59,995
+25% +$2.09M 0.19% 84
2020
Q1 		$8.27M Buy
243,682
+224,342
+1,160% +$8.98M 0.21% 77
2019
Q4 		$404K Sell
19,340
-984,342
-98% -$47.6M 0.43% 54
2019
Q3 		$50.1M Buy
1,003,682
+158,895
+19% +$8.11M 1.22% 27
2019
Q2 		$45.2M Sell
844,787
-1,596
-0.2% -$83.3K 1.04% 36
2019
Q1 		$44.9M Buy
846,383
+346,383
+69% +$18M 1.1% 34
2018
Q4 		$23.5M Buy
+500,000
New +$26.1M 0.61% 41

Other funds holding NTR

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Clal Insurance's NTR Position: Q1 2026 in Review

Clal Insurance reduced its Nutrien (NTR) stake by 8.8% in Q1 2026, selling an estimated $15M and leaving 2,175,282 shares worth $165M. The position accounts for 0.99% of the portfolio, ranked #23.

Clal Insurance first reported a position in NTR in Q4 2018 and has held it in 30 quarters since. The position peaked at $629M in Q1 2022. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • Clal Insurance held 2,175,282 shares of Nutrien worth $165M as of Q1 2026.
  • Clal Insurance sold 210,000 Nutrien shares in Q1 2026, an estimated $15M.
  • Nutrien made up 0.99% of Clal Insurance's portfolio in Q1 2026, its #23 holding.
  • Clal Insurance first reported a position in Nutrien in Q4 2018 and has held it in 30 quarters since.
  • Clal Insurance's Nutrien position peaked at $629M in Q1 2022.
  • 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on Clal Insurance's 13F filing for Q1 2026, filed 12 May 2026.